[1] Tang SA, Zhang C, Oo WM, et al. Osteoarthritis[J]. Nat Rev Dis Primers, 2025, 11(1): 10. [2] Duanmu Z, Liu L, Deng Q, et al. Development of a biomechanical model for dynamic occlusal stress analysis[J]. Int J Oral Sci, 2021, 13(1): 29. [3] Hu W, Chen Y, Dou C, et al. Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis[J]. Ann Rheum Dis, 2021, 80(4): 413-422. [4] Yang T, Zhang J, Cao Y, et al. Wnt5a/Ror2 mediates temporomandibular joint subchondral bone remodeling[J]. J Dent Res, 2015, 94(6): 803-812. [5] Yao Q, Wu X, Tao C, et al. Osteoarthritis: pathogenic signaling pathways and therapeutic targets[J]. Signal Transduct Target Ther, 2023, 8(1): 56. [6] Segarra-Queralt M, Crump K, Pascuet-Fontanet A, et al. The interplay between biochemical mediators and mechanotransduction in chondrocytes: Unravelling the differential responses in primary knee osteoarthritis[J]. Phys Life Rev, 2024, 48: 205-221. [7] Wang Y, Fan X, Xing L, et al. Wnt signaling: a promising target for osteoarthritis therapy[J]. Cell Commun Signal, 2019, 17(1): 97. [8] Mao G, Zhang Z, Hu S, et al. Exosomes derived from miR-92a-3p-overexpressing human mesenchymal stem cells enhance chondrogenesis and suppress cartilage degradation via targeting WNT5A[J]. Stem Cell Res Ther, 2018, 9(1): 247. [9] Ge X, Ma X, Meng J, et al. Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes[J]. Arthritis Rheum, 2009, 60(9): 2714-2722. [10] Kuang B, Zeng Z, Qin Q. Biomechanically stimulated chondrocytes promote osteoclastic bone resorption in the mandibular condyle[J]. Arch Oral Biol, 2019, 98: 248-257. [11] Kuang B, Dai J, Wang QY, et al. Combined degenerative and regenerative remodeling responses of the mandibular condyle to experimentally induced disordered occlusion[J]. Am J Orthod Dentofacial Orthop, 2013, 143(1): 69-76. [12] Ghasemi A, Jeddi S, Kashfi K. The laboratory rat: Age and body weight matter[J]. EXCLI J, 2021, 20: 1431-1445. [13] Kim S, Uroz M, Bays JL, et al. Harnessing mechanobiology for tissue engineering[J]. Dev Cell, 2021, 56(2): 180-191. [14] Gu XN, Lu Y, Wang F, et al. The effect of tensile and fluid shear stress on the in vitro degradation of magnesium alloy for stent applications[J]. Bioact Mater, 2018, 3(4): 448-454. [15] Lasch M, Kleinert EC, Meister S, et al. Extracellular RNA released due to shear stress controls natural bypass growth by mediating mechanotransduction in mice[J]. Blood, 2019, 134(17): 1469-1479. [16] Huang HM, Han CS, Cui SJ, et al. Mechanical force-promoted osteoclastic differentiation via periodontal ligament stem cell exosomal protein ANXA3[J]. Stem Cell Reports, 2022, 17(8): 1842-1858. [17] Katoh M, Katoh M. STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer[J]. Int J Mol Med, 2007, 19(2): 273-278. [18] Jafari S, Lavasanifar A, Hejazi MS, et al. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells[J]. Daru, 2020, 28(1): 159-169. [19] Wu Y, Wang Y, Liu B, et al. SN50 attenuates alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress syndrome mice through inhibiting NF-κB p65 translocation[J]. Respir Res, 2020, 21(1): 130. [20] Gan RH, Lin LS, Xie J, et al. FLI-06 intercepts notch signaling and suppresses the proliferation and self-renewal of tongue cancer cells[J]. Onco Targets Ther, 2019, 12: 7663-7674. [21] Grither WR, Baker B, Morikis VA, et al. ROR2/Wnt5a signaling regulates directional cell migration and early tumor cell invasion in ovarian cancer[J]. Mol Cancer Res, 2024, 22(5): 495-507. [22] Wakizaka K, Kamiyama T, Kakisaka T, et al. Expression of Wnt5a and ROR2, components of the noncanonical Wnt-signaling pathway, is associated with tumor differentiation in hepatocellular carcinoma[J]. Ann Surg Oncol, 2024, 31(1): 262-271. [23] Chen P, Zhou H, Yang X, et al. A-to-I-edited miR-1304-3p inhibits glycolysis and tumor growth of esophageal squamous cell carcinoma by inactivating Wnt5a/ROR2 signaling[J]. Mol Carcinog, 2025, 64(3): 552-564. |